As omicron continues to threaten world's recovery against the novel coronavirus, top Indian genome scientists have recommended a booster dose of COVID-19 vaccines for those above 40 years with preference to high-risk and high-exposure population.?Omicron is a new variant of concern and India has reported two cases of Omicron infection.
The recommendation was made in the weekly bulletin of the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of 28 national testing labs set up by the government to monitor genomic variations of COVID-19.?INSACOG checks variations in coronavirus across the nation to help understand how it spreads and evolves, and to suggest the best possible public health response.
¡°Vaccination of all remaining unvaccinated at-risk people and consideration of a booster dose for those 40 years of age and over, first targeting the most high-risk / high-exposure may be considered," the INSACOG bulletin said. The recommendation came amid demands for a booster dose of Covid vaccines by lawmakers during a discussion in the Lok Sabha on the pandemic situation in the country.
The US and Britain have already cleared booster shots for some age groups.Top American infectious diseases specialist Anthony Fauci stressed that fully vaccinated adults should seek a booster when eligible to give themselves the best possible protection.
INSACOG said preliminary evidence suggests that Omicron may increase reinfection risk, which is expected from the structural changes due to the mutations, and the number of cases of this variant appears to be increasing in almost all provinces in South Africa, where it was first detected.
Earlier on Thursday, the Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country.The officials informed that the demand has been made due to the emergence of a new coronavirus variant 'Omicron'.
The new Omicron variant was first reported to the World Health Organization (WHO) by South Africa on November 24. According to the WHO, its high number of mutations in spike protein could make it more transmissible than all previous strains. South African medical officials have reported the variant was found in fully vaccinated individuals and the cases are mild.
For more on news and current affairs from around the world, please visit Indiatimes News.?